Here’s a question almost nobody is asking: how do you get to the Times Square Olive Garden? Well, these beautiful weirdos are ...

Compass sued Zillow in June over its listing access standards, which threatened to ban listings that were not uploaded to its platform within 24 hours of being publicly marketed. Last month, a judge ...

Property brokerage Compass on Wednesday dropped its lawsuit against Zillow, ending a legal clash over how home listings can be marketed online. For the past few years, Compass — now the largest real ...

Brokerage Compass dropped its lawsuit against Zillow after the listings giant said it would allow some pre-marketed homes on its platform, ending a multi-month fight between two real estate giants ...

In brief: A few months after acquiring Arduino, Qualcomm is introducing its first product designed to combine its processor technology with the "maker" ethos of the Italian company. Unsurprisingly, ...

Five months after acquiring Arduino, the open-source hardware and software company best known for its UNO and Nano microcontroller board for hobbyists, Qualcomm is looking to make another big splash ...

Qualcomm, which purchased microcontroller board manufacturer Arduino last year, just announced a new single-board computer that marries AI with robotics. Called the Arduino Ventuno Q, it uses Qualcomm ...

Compass’ fourth-quarter earnings call this week came with more than bottom-line metrics. The company announced a three-year partnership with Rocket and Redfin. The “strategic alliance,” as Compass ...

Kanen bought 1,573,950 Compass shares; estimated trade size $14.36 million based on quarterly average price. Quarter-end Compass position value rose by $29.11 million, reflecting both trading and ...

Phase 3 clinical trial data has been a success. COMP360 is the first traditional psychedelic to consistently deliver a highly statistically significant outcome. Results included maintaining a ...

Compass Pathways has reported another phase 3 win for its psilocybin therapy in treatment-resistant depression, sending the British biotech’s share price up 30% and teeing up talks about filing for ...